GF Securities Co., Ltd. controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2023
CSRC case concerning share-issuance review
In April 2023, the China Securities Regulatory Commission filed a case against GF Securities concerning an alleged inadequate review of a share issuance. The supplied reference does not state the final regulatory outcome.
2020
Sponsorship and underwriting qualifications suspended for failure to exercise due diligence in Kangmei project
In 2020, GF Securities was subject to regulatory action for failing to exercise due diligence in the sponsorship and bond business of the Kangmei Pharmaceutical project. Its sponsor institution qualification and bond underwriting business were suspended for six months, relevant personnel were disciplined, and the company held multiple senior executives or responsible persons accountable. This incident concerns intermediary professional responsibility and is distinct from Kangmei's own financial fraud.